Congress has passed a sweeping biomedical innovation bill that President Obama has said he will sign. The bill provides the National Institutes of Health with $4.8 billion in extra money over 10 years to support three of the Obama administration’s biomedical research initiatives, although this funding has to be approved annually.
The House easily passed the bipartisan “21st Century Cures Act” yesterday. Among its numerous provisions, the bill allocates $4.8 billion over 10 years to the National Institutes of Health in support of the Obama administration’s Cancer Moonshot, BRAIN, and Precision Medicine Initiatives, and creates a Research Policy Board tasked with identifying means of reducing administrative burdens.
At a Senate hearing, appropriations subcommittee leaders disagreed on the advisability of the federal government embarking on an effort to spur the development and deployment of new types of nuclear reactors.
The National Nanotechnology Initiative has released the triennial update of its strategic plan. Among its new features, the plan now stresses the need to further develop the nanotechnology community’s collaboration “ecosystem” and to promote the development and sharing of data, computer models, and simulations.
In a letter to President-elect Donald Trump, the CEOs of 29 national scientific societies are calling on Trump to quickly appoint a science advisor and draw on S&T expertise to address national challenges.